Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
28 Apr 2020
App 4C - Quarterly Cash Flow Report - March 2020 Qtr
07 Apr 2020
Shares to be Released from Voluntary Escrow
25 Mar 2020
FDA Awards Orphan Drug Designation for Pancreatic Cancer
13 Feb 2020
Professor Paul Timpson Joins Amplia's SAB
12 Feb 2020
Initial Director's Interest Notice - John Lambert
07 Feb 2020
Final Director's Interest Notice - Behrenbruch
07 Feb 2020
Final Director's Interest Notice - Wilkinson
07 Feb 2020
Final Director's Interest Notice - Cooke
06 Feb 2020
Dr. John Lambert appointed as Managing Director
06 Feb 2020
Board Restructuring
Previous
1
2
3
4
5
6
7
Next
